Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
argenx SE - American Depositary Shares
(NQ:
ARGX
)
686.33
-19.70 (-2.79%)
Streaming Delayed Price
Updated: 11:11 AM EDT, Mar 18, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about argenx SE - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease
June 10, 2025
From
argenx SE
Via
GlobeNewswire
argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference
June 03, 2025
From
argenx SE
Via
GlobeNewswire
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
↗
June 02, 2025
Via
Benzinga
argenx Announces Results of Annual General Meeting of Shareholders
May 28, 2025
From
argenx SE
Via
GlobeNewswire
Earnings Scheduled For May 8, 2025
↗
May 08, 2025
Via
Benzinga
A Look Into argenx Inc's Price Over Earnings
↗
May 07, 2025
Via
Benzinga
P/E Ratio Insights for argenx
↗
April 29, 2025
Via
Benzinga
What's Driving the Market Sentiment Around argenx?
↗
April 21, 2025
Via
Benzinga
With Trials In Motion, Cash To 2027, Can Kyverna's Next Data Drop Turn The Stock Around?
↗
May 27, 2025
HC Wainwright upgrades Kyverna to Buy with a $5 target, citing upcoming trial data and a strong cash position that supports a runway into 2027.
Via
Benzinga
This Caterpillar Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
↗
May 13, 2025
Via
Benzinga
Eli Lilly, Affirm And Regeneron Are Among Top 12 Large-Cap Losers Last Week (May 5-May 9): Are The Others In Your Portfolio?
↗
May 11, 2025
The worst performing large-cap stocks last week: ARGENX, VRTX, SMMT, MMYT, REGN, RKT, BNTX, AFRM, FNF, LLY, AUR, DASH. Any in your portfolio?
Via
Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today
↗
May 09, 2025
Via
Benzinga
14 Analysts Have This To Say About argenx
↗
May 09, 2025
Via
Benzinga
Argenx Shares Drop After Q1 Miss, But Retail Traders Call Sub-$550 ‘An Absolute Steal’
↗
May 08, 2025
Despite the Q1 miss, management reiterated confidence in its long-term “Vision 2030” strategy, highlighting strong Vyvgart uptake in gMG and CIDP and the recent U.S. approval of a self-injection...
Via
Stocktwits
Topics
Earnings
Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings
↗
May 08, 2025
Via
Benzinga
Argenx Beats Sales Expectations — But Not By Enough — And Shares Tumble
↗
May 08, 2025
The company's drug treats two autoimmune conditions and recently launched with a prefilled synringe for at-home treatment.
Via
Investor's Business Daily
argenx Reports First Quarter 2025 Financial Results and Provides Business Update
May 08, 2025
From
argenx SE
Via
GlobeNewswire
argenx to Present at BofA Securities 2025 Health Care Conference
May 06, 2025
From
argenx SE
Via
GlobeNewswire
argenx to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025
May 01, 2025
From
argenx SE
Via
GlobeNewswire
argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
April 28, 2025
From
argenx SE
Via
GlobeNewswire
Does ARGENX SE - ADR (NASDAQ:ARGX) meet the Minervini criteria?
↗
April 26, 2025
A fundamental and technical analysis of (NASDAQ:ARGX): Is ARGENX SE - ADR (NASDAQ:ARGX) suited for high growth investing?
Via
Chartmill
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
↗
April 21, 2025
Via
Benzinga
Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years
↗
April 18, 2025
Via
Benzinga
FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting
↗
April 11, 2025
FDA approves Argenx's Vyvgart Hytrulo prefilled syringe for self-injection in gMG and CIDP, offering flexible dosing and expanding treatment options.
Via
Benzinga
argenx Announces Annual General Meeting of Shareholders on May 27, 2025
April 11, 2025
From
argenx SE
Via
GlobeNewswire
Argenx Bounds Off 200-Day Line On 'Best-Case Scenario' For Blockbuster Drug
↗
April 11, 2025
The prefilled syringe will cost 4% more than the under-the-skin shot.
Via
Investor's Business Daily
What 11 Analyst Ratings Have To Say About argenx
↗
April 11, 2025
Via
Benzinga
Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
↗
April 11, 2025
Via
Benzinga
argenx Announces FDA Approval of VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy
April 10, 2025
From
argenx SE
Via
GlobeNewswire
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline
↗
April 09, 2025
Trump hints at major tariffs on foreign pharmaceuticals, sparking concerns for Indian suppliers and potential hikes in U.S. drug costs.
Via
Benzinga
Topics
Government
Supply Chain
World Trade
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
